Respiratory failure & ventilation

The Predictive Validity of the Berlin Definition of Acute Respiratory Distress Syndrome for Patients With COVID-19-Related Respiratory Failure Treated With High-Flow Nasal Oxygen: A Multicenter, Prospective Cohort Study*

Crit Care MedPublished Prospective cohort study

Authors' conclusion

The predictive validity of the Berlin ARDS definition was similar for HFNO-treated patients as compared with the original population of invasively ventilated patients.

Study context

Population
High-flow nasal oxygen (HFNO)-treated adults (>18 years) with confirmed COVID-19-related acute respiratory failure meeting acute respiratory distress syndrome (ARDS) criteria (PaO2/FiO2 <300 mm Hg, bilateral infiltrates, worsening symptoms <1 week); 5 ICUs in Argentina, March 2020–September 20211,231 screened
Participants
696 adults
Exposure
Mild vs Moderate vs Severe
  • Mildn = 30
  • Moderaten = 380
  • Severen = 286
Outcome
Predictive validity of the Berlin definition for mortality (AUC)
Follow-up
Day 28
Methodological detailsmulticentre, consecutive inclusion
  • Multicentre
  • Consecutive inclusion

Main finding

As reported in the abstract

Predictive validity for mortality (AUC), study cohort

AUC

0.606

95% CI 0.561–0.651

Observational data: associations, not effects.

Further findings

Predictive validity across subgroups (subgroup) · day 28

AUC for subgroups similar to that of the overall cohort

Received invasive mechanical ventilation (IMV)

Patients receiving IMV
256 (37%)

Mortality · day 28

Died
142 (21%)
Deaths with severe ARDS
81 (57%)
Mortality occurred primarily in patients transitioned to IMV

Original publication

The Predictive Validity of the Berlin Definition of Acute Respiratory Distress Syndrome for Patients With COVID-19-Related Respiratory Failure Treated With High-Flow Nasal Oxygen: A Multicenter, Prospective Cohort Study*. Crit Care Med. Published 16 October 2023. doi:10.1097/ccm.0000000000006056

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.